Copy to clipboard 
Preclinical results demonstrate that Promimic’s HA Nano Surface coating technology can reduce the risk of adhesion by common pathogenic bacteria by up to 60%.
HA Nano Surface, is a nanometer-thin surface treatment that aims to improve the anchorage and healing of orthopedic and dental implants into bone tissue. The technology has been applied to over 700,000 implants in clinical use around the world.
The company’s recent in vitro study evaluated the adhesion of three common pathogenic bacterial strains to implants coated with HA Nano Surface. The results show that the ability of the bacteria to colonize the implant surface was reduced by 60%, which is of importance in preventing both infections and implant detachment in patients.
“Implant-related infections are a major challenge for modern healthcare, resulting in poor fixation, systemic infections and overuse of antibiotics. We are pleased with Promimic’s progress in countering this global challenge,” said Viktor Drvota, CEO, Karolinska Development. Promimic is a portfolio company of Karolinska Development AB.
